Equities

IXICO PLC

IXI:LSE

IXICO PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10.25
  • Today's Change0.00 / 0.00%
  • Shares traded73.59k
  • 1 Year change-12.77%
  • Beta1.1194
Data delayed at least 20 minutes, as of Feb 06 2026 16:12 GMT.
More ▼

Profile data is unavailable for this security.

About the company

IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.

  • Revenue in GBP (TTM)6.53m
  • Net income in GBP-1.65m
  • Incorporated1995
  • Employees79.00
  • Location
    IXICO PLC4th Fl, Griffin Court, 15 Long LaneLONDON EC1A 9PNUnited KingdomGBR
  • Phone+44 20 3763 7499Fax+44 20 7209 2473
  • Websitehttps://ixico.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Roquefort Therapeutics PLC0.00-882.45k1.96m1.001.96m1.00
ValiRx Plc49.78k-1.78m2.56m14.002.56m14.00
N4 Pharma PLC7.07k-1.07m3.95m4.003.95m4.00
TheraCryf PLC0.00-2.01m4.51m9.004.51m9.00
Ovoca Bio PLC0.0065.12k5.28m1.005.28m1.00
Cizzle Biotechnology Holdings PLC0.00-1.12m6.14m67.006.14m67.00
Futura Medical PLC7.93m-6.29m7.41m12.007.41m12.00
OptiBiotix Health PLC1.15m-191.00k7.90m5.007.90m5.00
IXICO PLC6.53m-1.65m9.50m79.009.50m79.00
Genflow Biosciences PLC0.00-1.80m10.36m5.0010.36m5.00
Solvonis Therapeutics PLC0.00-2.60m17.02m--17.02m--
Fusion Antibodies PLC1.60m-1.47m20.00m24.0020.00m24.00
Sareum Holdings Plc0.00-4.44m23.47m5.0023.47m5.00
Data as of Feb 06 2026. Currency figures normalised to IXICO PLC's reporting currency: UK Pound GBX

Institutional shareholders

48.77%Per cent of shares held by top holders
HolderShares% Held
Octopus Investments Ltd.as of 08 Dec 202516.85m18.18%
BGF Investment Management Ltd.as of 08 Dec 202512.89m13.91%
Canaccord Genuity Asset Management Ltd.as of 08 Dec 20257.47m8.06%
Unicorn Asset Management Ltd.as of 08 Dec 20253.86m4.16%
Hargreaves Lansdown Asset Management Ltd.as of 01 Nov 20252.54m2.74%
ICBC Standard Bank Plcas of 01 Nov 2025910.00k0.98%
HSBC Global Asset Management (UK) Ltd.as of 01 Nov 2025247.00k0.27%
IG Markets Ltd.as of 01 Nov 2025160.00k0.17%
Acadian Asset Management LLCas of 01 Nov 2025151.00k0.16%
Rathbones Investment Management Ltd.as of 01 Nov 2025115.00k0.12%
More ▼
Data from 30 Sep 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.